BOGGIO, Elena
 Distribuzione geografica
Continente #
EU - Europa 2.498
NA - Nord America 2.175
AS - Asia 1.452
SA - Sud America 191
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 6.388
Nazione #
US - Stati Uniti d'America 2.097
RU - Federazione Russa 609
SG - Singapore 434
IE - Irlanda 416
DE - Germania 378
IT - Italia 373
CN - Cina 355
HK - Hong Kong 216
SE - Svezia 207
VN - Vietnam 191
BR - Brasile 149
UA - Ucraina 121
FR - Francia 103
IN - India 89
GB - Regno Unito 82
FI - Finlandia 78
CA - Canada 52
KR - Corea 38
ES - Italia 25
PL - Polonia 25
BJ - Benin 23
ID - Indonesia 22
IR - Iran 21
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
MX - Messico 19
AR - Argentina 18
BD - Bangladesh 18
NL - Olanda 16
JP - Giappone 14
AT - Austria 13
IQ - Iraq 11
EC - Ecuador 8
TR - Turchia 8
GR - Grecia 7
LT - Lituania 7
BE - Belgio 6
CO - Colombia 5
KE - Kenya 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
JO - Giordania 4
LB - Libano 4
MA - Marocco 4
PH - Filippine 4
CL - Cile 3
DZ - Algeria 3
RO - Romania 3
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
PE - Perù 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.388
Città #
Dublin 411
San Jose 286
Hong Kong 214
Jacksonville 203
Singapore 200
Ashburn 171
Dearborn 109
Beijing 98
Chandler 97
Moscow 79
Dallas 66
Los Angeles 65
Wilmington 63
Grafing 61
Munich 61
Piemonte 60
Lauterbourg 55
Novara 54
Ho Chi Minh City 53
Lawrence 44
Princeton 44
Hanoi 42
Buffalo 38
New York 37
Seoul 37
Turin 33
Milan 32
San Mateo 31
São Paulo 28
Helsinki 27
Düsseldorf 25
Vercelli 25
Toronto 24
Cotonou 23
Orem 22
Bremen 20
Warsaw 20
Falkenstein 19
Poplar 19
Frankfurt am Main 18
Council Bluffs 17
London 17
Santa Clara 17
The Dalles 17
Ann Arbor 16
Brno 16
Brooklyn 15
Denver 15
Amsterdam 14
Johannesburg 14
Monmouth Junction 14
Andover 13
Redondo Beach 13
Tokyo 13
Kunming 12
Montreal 12
Phoenix 12
Chennai 11
Chicago 11
Jakarta 11
Atlanta 10
Boardman 10
Boston 10
Guangzhou 10
Hefei 10
Mülheim 10
Manchester 9
Norwalk 9
Nuremberg 9
San Giuliano Milanese 9
Tianjin 9
Zanjan 9
Dong Ket 8
Houston 8
Nanjing 8
Querétaro 8
Rome 8
Vienna 8
Baghdad 7
Belo Horizonte 7
Can Tho 7
Jinan 7
Mexico City 7
Stockholm 7
Turku 7
Ardabil 6
Assago 6
Cassano Magnago 6
Da Nang 6
Haiphong 6
Hillsboro 6
Mumbai 6
Ottawa 6
Paris 6
Torino 6
Barnet 5
Berlin 5
Borgomanero 5
Brussels 5
Bulandshahr 5
Totale 3.590
Nome #
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles 160
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 158
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. 154
Anti-cytokine autoantibodies in autoimmune diseases 147
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation 145
A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock 145
Osteopontin binds ICOSL promoting tumor metastasis 144
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 143
B7h Triggering Inhibits the Migration of Tumor Cell Lines 143
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 143
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 142
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 140
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 133
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes 131
B7H triggering inhibits osteoclast function in vitro and in vivo 130
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 123
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 122
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 121
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator 121
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 117
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 117
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 117
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 113
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 112
Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells 111
Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative 109
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 106
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 105
Vitamin D Supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of Children with Type 1 Diabetes 102
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 101
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 99
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies 97
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 96
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 96
Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release. 96
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 95
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 94
Variations of the perforin gene in patients with multiple sclerosis 93
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 90
The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report 90
Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. 89
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells. 86
Role of the C-terminal fragment of osteopontin in multiple sclerosis 86
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment 85
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment 83
Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype. 83
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 82
Sr-Containing Mesoporous Bioactive Glasses Bio-Functionalized with Recombinant ICOS-Fc: An In Vitro Study 79
Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling 78
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 76
Serum levels of osteopontin are increased in SIRS and sepsis 75
Paclitaxel-loaded nanosponges inhibit growth and angiogenesis in melanoma cell models 75
Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study 75
Genes and Microbiota Interaction in Monogenic Autoimmune Disorders 75
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications 73
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma 72
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 69
The role of osteopontin/anti-osteopontin antibodies in CIDP 68
A Computational Model for the Release of Bioactive Molecules by the Hydrolytic Degradation of a Functionalized Polyester-Based Scaffold 67
Tuning of the immune response using peptides loaded in biocompatible and biodegradable nanoparticles 65
null 62
Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures 49
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients 34
Totale 6.487
Categoria #
all - tutte 29.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 13 39 8
2021/2022443 44 7 28 32 19 15 82 14 29 37 42 94
2022/2023919 58 45 71 11 64 72 30 54 436 14 41 23
2023/2024392 31 26 35 11 51 12 98 13 0 7 39 69
2024/2025834 30 13 39 19 30 70 83 87 190 63 32 178
2025/20262.885 152 129 214 449 335 219 488 477 210 212 0 0
Totale 6.487